248 related articles for article (PubMed ID: 7714101)
1. Do androgens regulate growth hormone-binding protein in adult man?
Ip TP; Hoffman DM; O'Sullivan AJ; Leung KC; Ho KK
J Clin Endocrinol Metab; 1995 Apr; 80(4):1278-82. PubMed ID: 7714101
[TBL] [Abstract][Full Text] [Related]
2. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
3. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
5. Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods.
Rajkovic IA; Valiontis E; Ho KK
J Clin Endocrinol Metab; 1994 Mar; 78(3):772-7. PubMed ID: 8126156
[TBL] [Abstract][Full Text] [Related]
6. Testosterone administration increases insulin-like growth factor-I levels in normal men.
Hobbs CJ; Plymate SR; Rosen CJ; Adler RA
J Clin Endocrinol Metab; 1993 Sep; 77(3):776-9. PubMed ID: 7690364
[TBL] [Abstract][Full Text] [Related]
7. Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization.
Weissberger AJ; Ho KK
J Clin Endocrinol Metab; 1993 Jun; 76(6):1407-12. PubMed ID: 8501143
[TBL] [Abstract][Full Text] [Related]
8. Androgen regulation of growth hormone binding protein.
Keenan BS; Richards GE; Mercado M; Dallas JS; Eakman GD; Baumann G
Metabolism; 1996 Dec; 45(12):1521-6. PubMed ID: 8969286
[TBL] [Abstract][Full Text] [Related]
9. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Gleeson HK; Shalet SM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
[TBL] [Abstract][Full Text] [Related]
10. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
[TBL] [Abstract][Full Text] [Related]
11. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O
J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565
[TBL] [Abstract][Full Text] [Related]
12. Serum growth hormone-binding protein is unchanged in adult panhypopituitarism.
Davila N; Alcañiz J; Salto L; Estrada J; Barcelo B; Baumann G
J Clin Endocrinol Metab; 1994 Nov; 79(5):1347-50. PubMed ID: 7962328
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.
Hayes VY; Urban RJ; Jiang J; Marcell TJ; Helgeson K; Mauras N
J Clin Endocrinol Metab; 2001 May; 86(5):2211-9. PubMed ID: 11344229
[TBL] [Abstract][Full Text] [Related]
14. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
Jockenhövel F; Blum WF; Vogel E; Englaro P; Müller-Wieland D; Reinwein D; Rascher W; Krone W
J Clin Endocrinol Metab; 1997 Aug; 82(8):2510-3. PubMed ID: 9253326
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
16. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
[TBL] [Abstract][Full Text] [Related]
17. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. I. Serum growth hormone-binding protein.
Martha PM; Rogol AD; Carlsson LM; Gesundheit N; Blizzard RM
J Clin Endocrinol Metab; 1993 Aug; 77(2):452-7. PubMed ID: 8345051
[TBL] [Abstract][Full Text] [Related]
19. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
20. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.
Fisker S; Jorgensen JO; Vahl N; Orskov H; Christiansen JS
Eur J Endocrinol; 1999 Dec; 141(6):601-8. PubMed ID: 10601963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
